The metabolic bone disease associated with the Hyp mutation is independent of osteoblastic HIF1α expression

Fibroblast growth factor-23 (FGF23) controls key responses to systemic phosphate increases through its phosphaturic actions on the kidney. In addition to stimulation by phosphate, FGF23 positively responds to iron deficiency anemia and hypoxia in rodent models and in humans. The disorder X-linked hy...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Julia M. Hum, Erica L. Clinkenbeard, Colin Ip, Taryn A. Cass, Matt Allen, Kenneth E. White
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2017-06-01
Цуврал:	Bone Reports
Нөхцлүүд:	FGF23 Phosphate Hypoxia inducible factor-1α X-linked hypophosphatemia
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2352187217300037
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!